Lindsay J - Search Results

1

Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.

Steinberg DH, Shah P, Kinnaird T, Pinto Slottow TL, Roy PK, Okabe T, Bonello L, de Labriolle A, Smith KA, Torguson R, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R. Steinberg DH, et al. Among authors: lindsay j. Am J Cardiol. 2008 Jul 15;102(2):160-4. doi: 10.1016/j.amjcard.2008.03.030. Epub 2008 May 28. Am J Cardiol. 2008. PMID: 18602514

2

Device selection in the treatment of in-stent restenosis with and without radiation (from the Gamma Radiation Trials).

Ajani AE, Waksman R, Zimarino M, Kim HS, Pichard AD, Satler LF, Kent KM, White RL, Pinnow E, Mehran R, Lansky A, Lindsay J. Ajani AE, et al. Among authors: lindsay j. Am J Cardiol. 2002 Jan 15;89(2):137-44. doi: 10.1016/s0002-9149(01)02189-0. Am J Cardiol. 2002. PMID: 11792331 Clinical Trial.

3

The outcome of percutaneous coronary intervention in patients with in-stent restenosis who failed intracoronary radiation therapy.

Ajani AE, Waksman R, Cheneau E, Cha DH, McGlynn S, Castagna M, Chan RC, Satler LF, Kent KM, Pichard AD, Pinnow E, Lindsay J. Ajani AE, et al. Among authors: lindsay j. J Am Coll Cardiol. 2003 Feb 19;41(4):551-6. doi: 10.1016/s0735-1097(02)02859-0. J Am Coll Cardiol. 2003. PMID: 12598064 Free article.

4

Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.

Kinnaird TD, Stabile E, Mintz GS, Lee CW, Canos DA, Gevorkian N, Pinnow EE, Kent KM, Pichard AD, Satler LF, Weissman NJ, Lindsay J, Fuchs S. Kinnaird TD, et al. Among authors: lindsay j. Am J Cardiol. 2003 Oct 15;92(8):930-5. doi: 10.1016/s0002-9149(03)00972-x. Am J Cardiol. 2003. PMID: 14556868

5

Comparison of baseline characteristics and one-year outcomes between African-Americans and Caucasians undergoing percutaneous coronary intervention.

Leborgne L, Cheneau E, Wolfram R, Pinnow EE, Canos DA, Pichard AD, Suddath WO, Satler LF, Lindsay J, Waksman R. Leborgne L, et al. Among authors: lindsay j. Am J Cardiol. 2004 Feb 15;93(4):389-93. doi: 10.1016/j.amjcard.2003.10.029. Am J Cardiol. 2004. PMID: 14969608

6

Use of IIb/IIIa inhibitors in patients with in-stent restenosis treated with intracoronary gamma-radiation. Integrilin WRIST.

Waksman R, Ajani AE, Gruberg L, Pinnow E, GebreEyesus A, Deible R, Satler LF, Pichard AD, Torguson R, Kent KM, Suddath W, Lindsay J. Waksman R, et al. Among authors: lindsay j. Catheter Cardiovasc Interv. 2004 Jun;62(2):162-6. doi: 10.1002/ccd.20054. Catheter Cardiovasc Interv. 2004. PMID: 15170704 Clinical Trial.

7

Clinical, angiographic, and intravascular ultrasound characteristics of early saphenous vein graft failure.

Caños DA, Mintz GS, Berzingi CO, Apple S, Kotani J, Pichard AD, Satler LF, Suddath WO, Waksman R, Lindsay J Jr, Weissman NJ. Caños DA, et al. Among authors: lindsay j jr. J Am Coll Cardiol. 2004 Jul 7;44(1):53-6. doi: 10.1016/j.jacc.2004.03.045. J Am Coll Cardiol. 2004. PMID: 15234406 Free article.

8

Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine.

Lindsay J, Canos DA, Apple S, Pinnow E, Aggrey GK, Pichard AD. Lindsay J, et al. Am J Cardiol. 2004 Sep 15;94(6):786-9. doi: 10.1016/j.amjcard.2004.06.007. Am J Cardiol. 2004. PMID: 15374790

9

Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study.

Waksman R, Ajani AE, Pichard AD, Torguson R, Pinnow E, Canos D, Satler LF, Kent KM, Kuchulakanti P, Pappas C, Gambone L, Weissman N, Abbott MC, Lindsay J; Oral Rapamune to Inhibit Restenosis study. Waksman R, et al. Among authors: lindsay j. J Am Coll Cardiol. 2004 Oct 6;44(7):1386-92. doi: 10.1016/j.jacc.2004.06.069. J Am Coll Cardiol. 2004. PMID: 15464317 Free article. Clinical Trial.

10

Addition of heparin to contrast media is associated with increased bleeding and peripheral vascular complications during percutaneous coronary intervention with bivalirudin and drug-eluting stents.

Rha SW, Kuchulakanti PK, Pakala R, Cheneau E, Pinnow E, Gebreeyesus A, Aggrey G, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Rha SW, et al. Among authors: lindsay j. Cardiovasc Radiat Med. 2004 Apr-Jun;5(2):64-70. doi: 10.1016/j.carrad.2004.06.003. Cardiovasc Radiat Med. 2004. PMID: 15464942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,560 results

Search Page

Filters